scispace - formally typeset
M

Mirjana Efremova

Researcher at Wellcome Trust Sanger Institute

Publications -  43
Citations -  9462

Mirjana Efremova is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Immune system & Cancer immunotherapy. The author has an hindex of 19, co-authored 40 publications receiving 4524 citations. Previous affiliations of Mirjana Efremova include Innsbruck Medical University & Queen Mary University of London.

Papers
More filters
Journal ArticleDOI

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

TL;DR: The immunophenoscore was a superior predictor of response to anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) and anti-programmed cell death protein 1 (anti-PD-1) antibodies in two independent validation cohorts and may help inform cancer immunotherapy and facilitate the development of precision immuno-oncology.
Journal ArticleDOI

CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes.

TL;DR: The structure and content of CellPhoneDB is outlined, procedures for inferring cell–cell communication networks from single-cell RNA sequencing data are provided and a practical step-by-step guide to help implement the protocol is presented.
Posted ContentDOI

Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade

TL;DR: Cellular characterization of the immune infiltrates revealed a role of cancer-germline antigens in spontaneous immunity and showed that tumor genotypes determine immunophenotypes and tumor escape mechanisms and a scoring scheme for the quantification termed immunophenoscore was developed.